Posted on 11/12/20
Holy Cross Healthplex Wound Healing and Hyperbaric Program Focuses on Diabetes- Related Chronic Wounds During Diabetes Awareness Month
In recognition of Diabetes Awareness Month in November, Holy Cross Health is partnering with Healogics®, the nation’s leading provider of advanced wound care to educate the . . .
Posted on 11/10/20
Tampa General Hospital CEO John Couris Named to Florida Council of 100, Recognized as One of Florida's Most Influential Leaders
John Couris, Tampa General Hospital president and CEO, is one of the newest members of The Florida Council of 100, a private, not-for-profit organization comprised of . . .
Posted on 11/10/20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the third quarter ended . . .
Posted on 11/10/20
Seneca Biopharma Reports 2020 Third Quarter Results
Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for . . .
Posted on 11/10/20
TherapeuticsMD Prices of $30 Million Public Offering of Common Stock
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the pricing of its underwritten public offering of approximately 23.4 million shares of its common stock for gross . . .
Posted on 11/10/20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today reported financial results . . .
Posted on 11/10/20
Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported pipeline . . .
Posted on 11/10/20
Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene . . .
Posted on 11/10/20
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous . . .
Posted on 11/10/20
Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
MALVERN, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, . . .
Posted on 11/10/20
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
Norwood, MA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 11/10/20
Cabaletta Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell . . .
Posted on 11/10/20
Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass. and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and . . .
Posted on 11/10/20
Arch Raises Approximately $1.1 Million with Convertible Notes
FRAMINGHAM, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), developer of novel self-assembling wound care and biosurgical devices, announces that it has . . .
Posted on 11/10/20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
BALA CYNWYD, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today . . .
Posted on 11/10/20
Precision BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical-stage biotechnology company dedicated to improving life with its novel and proprietary . . .
Posted on 11/10/20
Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 11/10/20
AlloVir Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial results for the third quarter ended . . .
Posted on 11/10/20
Adagio Therapeutics Raises $80M Series B
Adagio Therapeutics, Inc., a company developing best-in-class antibodies that broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses, today announced the closing of an $80 million . . .
Posted on 11/10/20
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
What happenedDevelopmental-stage COVID-19 vaccine stocks continued their recent downward trend last month. Over the course of October, for instance, Inovio Pharmaceuticals (NASDAQ:INO) lost 16.1% of its . . .
Posted on 11/10/20
Coronavirus Vaccine Candidate From Pfizer and BioNTech Leaps Over Efficacy Hurdle
Buck up campers, it might all be over soon. On Monday morning, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced success with their coronavirus vaccine candidate, BNT162b2, following . . .
Posted on 11/10/20
Pfizer Vaccine News Pumps Up Oil Prices
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced this morning that their coronavirus vaccine candidate BNT162b2 is showing 90% effectiveness in phase 3 clinical trials. The companies are . . .
Posted on 11/10/20
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
What happenedDevelopmental-stage COVID-19 vaccine stocks continued their recent downward trend last month. Over the course of October, for instance, Inovio Pharmaceuticals (NASDAQ:INO) lost 16.1% of its . . .
Posted on 11/10/20
Here's Why Vertex Pharmaceuticals Fell 23.4% in October
What happenedShares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 23.4% in October, according to data from S&P Global Market Intelligence after the biotech discontinued development of a drug . . .
Posted on 11/10/20
3 Reasons CVS Health Is a Top Healthcare Stock to Buy Now
Shares of CVS Health (NYSE:CVS) leaped higher following an encouraging third-quarter earnings report. Signs of endurance through the COVID-19 pandemic inspired a lot of new investors . . .

